OMKARCHEM
Omkar Speciality Chemicals Limited
Omkar Speciality Chemicals Limited (OMKARCHEM) financial statements and selected valuation metrics through 30 June 2026.
Key metrics
ROE (FY26)
-8.5%
ROCE (FY26)
-7.3%
Operating margin (FY26)
-21318.3%
Debt / equity (FY26)
0.17
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What we see
Positives
- ✓Debt-to-equity of 0.17x — the company is largely funded by its own money, not borrowed funds.
Concerns
- ✗Net margin is negative — the company is spending more than it earns right now.
1 more signal from the filings.Sign in free to see them all
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2020 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12 Cr | 7 Cr | 4 Cr | 6 Cr | 5 Cr | 4 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0.0082 Cr | 0 Cr |
| Operating expenses (approx.) | 9 Cr | 8 Cr | 7 Cr | 6 Cr | 8 Cr | 5 Cr | 0.24 Cr | 0.20 Cr | 0.37 Cr | 0.11 Cr | 0.19 Cr | 0.14 Cr |
| EBITDA | 3 Cr | -0.40 Cr | -2 Cr | 0.13 Cr | -3 Cr | -0.95 Cr | -0.24 Cr | -0.20 Cr | -0.37 Cr | -0.11 Cr | -0.18 Cr | -0.14 Cr |
| OPM % | 24.3% | -5.4% | -55.0% | 2.0% | -61.7% | -25.3% | — | — | — | — | -2174.4% | — |
| Other income | 0.55 Cr | 0.02 Cr | 0.72 Cr | 0.01 Cr | 0.21 Cr | 0.12 Cr | 0.08 Cr | 0.0086 Cr | 0.08 Cr | 0.0082 Cr | 0.07 Cr | 0 Cr |
| Interest | 2 Cr | 1 Cr | 1 Cr | 2 Cr | 2 Cr | 2 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Depreciation | 0.98 Cr | 0.47 Cr | 0.47 Cr | 0.40 Cr | 0.44 Cr | 0.39 Cr | 0.22 Cr | 0.22 Cr | 0.23 Cr | 0.23 Cr | 0.22 Cr | 0.22 Cr |
| Profit before tax | 1 Cr | -2 Cr | -4 Cr | -2 Cr | -5 Cr | -3 Cr | -0.39 Cr | -0.41 Cr | -0.52 Cr | -0.33 Cr | -0.33 Cr | -0.36 Cr |
| Tax % | 39.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net profit | 0.61 Cr | -2 Cr | -4 Cr | -2 Cr | -5 Cr | -3 Cr | -0.39 Cr | -0.41 Cr | -0.52 Cr | -0.33 Cr | -0.33 Cr | -0.36 Cr |
| EPS (₹) | ₹0.30 | ₹-1.11 | ₹-1.73 | ₹-0.89 | ₹-2.39 | ₹-1.41 | ₹-0.19 | ₹-0.20 | ₹-0.25 | ₹-0.16 | ₹-0.16 | ₹-0.18 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 345 Cr | 198 Cr | 43 Cr | 57 Cr | 23 Cr | 0 Cr | 0.0082 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 288 Cr | 241 Cr | 44 Cr | 57 Cr | 29 Cr | 0.62 Cr | 0.86 Cr | Sign in free for the trailing twelve months |
| EBITDA | 57 Cr | -43 Cr | -1 Cr | -0.24 Cr | -6 Cr | -0.62 Cr | -0.85 Cr | Sign in free for the trailing twelve months |
| OPM % | 16.6% | -21.9% | -3.1% | -0.4% | -24.8% | — | -10425.6% | Sign in free for the trailing twelve months |
| Other income | 2 Cr | 4 Cr | 2 Cr | 0.45 Cr | 0.96 Cr | 0.22 Cr | 0.16 Cr | Sign in free for the trailing twelve months |
| Interest | 22 Cr | 26 Cr | 15 Cr | 5 Cr | 6 Cr | 0 Cr | 0 Cr | Sign in free for the trailing twelve months |
| Depreciation | 11 Cr | 8 Cr | 8 Cr | 7 Cr | 2 Cr | 0.91 Cr | 0.89 Cr | Sign in free for the trailing twelve months |
| Profit before tax | -137 Cr | -127 Cr | -12 Cr | -11 Cr | -13 Cr | -1 Cr | -2 Cr | Sign in free for the trailing twelve months |
| Tax % | 20.1% | 17.8% | -46.5% | -29.4% | 0.0% | 0.0% | 0.0% | Sign in free for the trailing twelve months |
| Net profit | -109 Cr | -104 Cr | -17 Cr | -15 Cr | -13 Cr | -1 Cr | -2 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹-53.14 | ₹-50.40 | ₹-8.20 | ₹-7.11 | ₹-6.13 | ₹-0.63 | ₹-0.77 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | — | — | — | Sign in free for the trailing twelve months |
Sign in free for the trailing twelve months
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 21 Cr | 21 Cr | 21 Cr | 21 Cr | 21 Cr | 21 Cr | 21 Cr |
| Reserves | -23 Cr | -146 Cr | -197 Cr | -183 Cr | 0 Cr | -377 Cr | -2 Cr |
| Borrowings | 170 Cr | 223 Cr | — | 223 Cr | — | 382 Cr | 3 Cr |
| Other liabilities | 140 Cr | 38 Cr | — | 36 Cr | — | 22 Cr | 24 Cr |
| Total liabilities | 307 Cr | 136 Cr | — | 97 Cr | — | 48 Cr | 46 Cr |
| Fixed assets (net) | 82 Cr | 76 Cr | — | 53 Cr | — | 20 Cr | 19 Cr |
| CWIP | — | — | — | — | — | — | 0.20 Cr |
| Investments | 0.14 Cr | 11 Cr | — | 0.38 Cr | — | 0.07 Cr | 0.07 Cr |
| Inventories | 71 Cr | 4 Cr | — | 4 Cr | — | 0.01 Cr | 0.0061 Cr |
| Trade receivables | 78 Cr | 10 Cr | — | 5 Cr | — | 0 Cr | 0 Cr |
| Cash & bank | 4 Cr | 1 Cr | — | 0.31 Cr | — | 2 Cr | 0.38 Cr |
| Other assets | 71 Cr | 33 Cr | — | 35 Cr | — | 26 Cr | 26 Cr |
| Total assets | 307 Cr | 136 Cr | — | 97 Cr | — | 48 Cr | 46 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 107 Cr | 26 Cr | 1 Cr | 4 Cr | 0.89 Cr | 0.90 Cr | -2 Cr |
| Cash from investing | -120 Cr | -64 Cr | 11 Cr | 2 Cr | 0.17 Cr | 0.34 Cr | -0.13 Cr |
| Cash from financing | 16 Cr | 35 Cr | -14 Cr | -5 Cr | -1 Cr | 0 Cr | -0.05 Cr |
| Net cash flow | 3 Cr | -3 Cr | -1 Cr | 0.23 Cr | 0.03 Cr | 1 Cr | -2 Cr |
| Free cash flow (OCF − Capex) | 18 Cr | -28 Cr | 1 Cr | 4 Cr | 0.89 Cr | 0.90 Cr | -2 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | — | — | — | — | — | -7.3% |
| ROE % | — | — | — | — | — | — | -8.5% |
| Debtor days | 82 | 19 | — | 30 | — | — | 0 |
| Inventory days | 132 | 10 | — | 32 | — | — | 271 |
| Days payable | 221 | 43 | — | 148 | — | — | 0 |
| Cash conversion cycle | -7 | -13 | — | -87 | — | — | 271 |
| OCF / EBITDA % | 187.2% | — | — | — | — | — | — |
| OCF / EBITDA % (3 years) | — | — | n.m. | — | — | — | — |
| Debt / equity | — | — | — | — | — | 0.00 | 0.17 |
| Current ratio | 0.76 | 0.19 | — | 0.16 | — | 0.04 | 3.63 |
| Net debt / EBITDA | 2.88 | — | — | — | — | — | — |